SHARPE
Reported results
- Sales increased 7% to $11.1 billion in Q3 2026 from $10.4 billion in Q3 2025
- Diluted earnings per share (GAAP) of $7.89 in Q3 2026 compared to $7.67 in Q3 2025
- Segment operating margin rate (non-GAAP) of 12.1% in Q3 2026 compared to 12.3% in Q3 2025
- Operating margin rate (GAAP) of 11.4% in Q3 2026 compared to 11.9% in Q3 2025
- Backlog increased to $109.6 billion at September 30, 2026 from $95.7 billion at December 31, 2025
- Book to bill ratio of 1.5x; net awards in Q3 2026 totaled $16.4 billion
Guidance
- 2026 Sales guidance: $43,750 million to $44,250 million
- 2026 Segment operating income (non-GAAP) guidance: $4,940 million to $5,040 million (raised from prior $4,850 million to $5,000 million)
- 2026 MTM-adjusted EPS (non-GAAP) guidance: $29.35 to $29.75 (raised from prior $28.60 to $29.10)
- 2026 Adjusted free cash flow (non-GAAP) guidance: $3,100 million to $3,500 million
Notes
The company raised 2026 guidance for Segment operating income (non-GAAP) by $65 million at the midpoint and MTM-adjusted EPS (non-GAAP) by $0.70 at the midpoint. Non-GAAP measures included throughout; definitions provided in release.
Price and volatility reaction
The stock moved +4.6% on the print. No front-expiry chain was on file, so there is no straddle expected move.
| Measure | Value | Basis |
|---|---|---|
| Close before release | 510.65 | 2026-10-19 |
| Close after release | 534 | 2026-10-20 |
| Realised move | +4.6% | close to close |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-20 (8-K, Item 2.02). Read the original filing on sec.gov.